Kamada Ltd. Opens New Plasma Collection Site in Houston
Ticker: KMDA · Form: 6-K · Filed: Sep 23, 2024 · CIK: 1567529
| Field | Detail |
|---|---|
| Company | Kamada Ltd (KMDA) |
| Form Type | 6-K |
| Filed Date | Sep 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, expansion, plasma-collection
TL;DR
Kamada opens new plasma center in Houston, Texas to boost supply.
AI Summary
Kamada Ltd. announced on September 23, 2024, the expansion of its plasma collection operations in Texas with the opening of a new site in Houston. This expansion is part of the company's strategy to increase its plasma supply capabilities.
Why It Matters
The expansion of plasma collection sites directly impacts Kamada's ability to secure raw materials for its plasma-derived therapeutics, potentially affecting production capacity and future revenue streams.
Risk Assessment
Risk Level: low — This filing is an operational update and does not contain significant financial or strategic shifts that would inherently increase risk.
Key Players & Entities
- Kamada Ltd. (company) — Registrant
- Houston (location) — New plasma collection site location
- Texas (location) — State where new plasma collection site is located
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed by Kamada Ltd. to report the expansion of its plasma collection operations in Texas with the opening of a new site in Houston.
When was this announcement made?
The announcement regarding the new plasma collection site was made on September 23, 2024.
Where is the new plasma collection site located?
The new plasma collection site is located in Houston, Texas.
What is Kamada Ltd.'s primary business related to this announcement?
Kamada Ltd. is involved in plasma collection operations, which are essential for its plasma-derived therapeutics.
How is this Form 6-K being used in relation to other filings?
This Form 6-K is being incorporated by reference into Kamada Ltd.'s Form S-8 Registration Statements, specifically File Nos. 333-192720, 333-207933, 333-215983, 333-222891, 333-233267, and 333-265866.
Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-09-23 07:00:24
Filing Documents
- ea0215359-6k_kamada.htm (6-K) — 11KB
- ea021535901ex99-1_kamada.htm (EX-99.1) — 15KB
- 0001213900-24-080801.txt ( ) — 28KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of September 2024 Commission File Number 001-35948 Kamada Ltd. (Translation of registrant’s name into English) 2 Holzman Street Science Park, P.O. Box 4081 Rehovot 7670402 Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements, File Nos. 333-192720 , 333-207933 , 333-215983 , 333-222891 , 333-233267 and 333-265866 . The following exhibit is attached: 99.1 Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 23, 2024 KAMADA LTD. By: /s/ Nir Livneh Nir Livneh Vice President General Counsel and Corporate Secretary 2 EXHIBIT INDEX EXHIBIT NO. DESCRIPTION 99.1 Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston 3